Reversible cross-linked hydrogels and methods of cluster amplification using same
By using reversible crosslinking technology in hydrogels, using different types of functional groups to form a controllable crosslinking network, the stability of hydrogels during transportation and storage is solved, and the efficiency of cluster amplification and sequencing signals are improved. accuracy.
Patent Information
- Application Number
- CN202380031852.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-11-21
- Filing Date
- 2023-11-20
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing hydrogels tend to collapse irreversibly during transportation and storage, resulting in inaccessibility of amplification primers, reducing the efficiency of cluster amplification and the accuracy of sequencing reads.
Reversible crosslinking hydrogels are used to form a controllable crosslinking network by coupling different types of functional groups on the polymer chain, limiting polymer chain mobility, improving the stability of the hydrogel, and chemically passing through Reverse cross-linking of agents, enzymes, light or heat to return to the open state.
The stability of the hydrogel during transportation and storage is significantly improved, the inoculation events during cluster amplification is reduced, the monoclonality and amplification efficiency of the cluster is improved, and the accuracy of the sequencing signal is enhanced.
Smart Images

Figure CN119095980A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 427,018, filed on November 21, 2022, entitled “Reversibly Cross-Linked Hydrogels, and Methods of Using the Same for Cluster Amplification,” the disclosure of which is hereby incorporated by reference in its entirety. Technical Field
[0003] The present application relates to hydrogels, such as hydrogels useful for cluster amplification. Background Art
[0004] Cluster amplification is a method for amplifying polynucleotides, such as for gene sequencing. The target polynucleotide is captured by primers (e.g., P5 and P7 primers) coupled to the substrate surface in a flow cell, and "seeds" are formed at random positions on the surface. Amplification cycles are performed to form clusters on the surface around each seed. These clusters include copies and complementary copies of the seed polynucleotide. In some cases, the substrate is patterned to define the area in which different clusters are combined, such as holes that can be filled with corresponding clusters. Summary of the invention
[0005] Examples provided herein relate to reversibly cross-linked hydrogels, and methods of using the same for cluster amplification.
[0006] Some examples herein provide hydrogels on a substrate. The hydrogel may include a three-dimensional network of polymer chains. The hydrogel may include a first functional group coupled to the polymer chains. The hydrogel may include an amplification primer coupled to the polymer chains via the first functional group. The hydrogel may include a second functional group coupled to the polymer chains and reversibly cross-linking the polymer chains to each other.
[0007] In some examples, the types of the first functional group and the second functional group are different from each other. In other examples, the types of the first functional group and the second functional group are the same as each other. In some examples, the first functional group and the second functional group are independently selected from the group consisting of: azide, amine, thiol, diol, aldehyde, alkyne, strained cyclooctyne and inverse electron demand (IED) Diels-Alder group.
[0008] In some examples, the second functional group reversibly cross-links the polymer chain via a cleavable molecule. In some examples, the cleavable molecule can be cleaved using a chemical agent, an enzyme, light or heat. In some examples, the chemical agent includes an acid. In some examples, the cleavable molecule includes an acetal, a ketal, an imine, a hydrazone or a tert-butyl ester that can be cleaved by an acid. In other examples, the chemical agent includes a reducing agent. In some examples, the cleavable molecule includes a disulfide bond or an azido alkyl ether that can be cleaved using a reducing agent, or an allyl ether that can be cleaved using a palladium complex of a reducing agent. In other examples, the enzyme includes a DNA enzyme, an RNA enzyme, a protease or a restriction enzyme, and wherein the cleavable molecule includes an oligonucleotide that can be cleaved using a DNA enzyme, an RNA enzyme, a protease or a restriction enzyme. In other examples, the enzyme includes a protease enzyme or a lysosomal enzyme, and wherein the cleavable molecule includes a peptide that can be cleaved using a protease enzyme or a lysosomal enzyme. In other examples, the cleavable molecule includes a Diels-Alder conjugation that can be cleaved using heat. In other examples, the cleavable molecule includes a coumarin or nitrophenyl group that can be cleaved using light.
[0009] In some examples, the second functional group includes a host molecule that reversibly crosslinks the main chain via a guest molecule. In some examples, the guest molecule can be removed via salt, heat or pH. Additionally or alternatively, in some examples, the guest molecule can be removed via displacement of a binding partner with the guest molecule. Additionally or alternatively, in some examples, the host molecule includes a crown ether and the guest molecule includes an ammonium moiety. Additionally or alternatively, the host molecule includes β-cyclodextrin, and the guest molecule includes adamantane, ferrocene or bipyridine. In some examples, the second functional group includes a ligand molecule that reversibly crosslinks the main chain via a multivalent binding protein. In some examples, the multivalent binding protein can be removed using a denaturant.
[0010] Some examples herein provide methods of using a hydrogel. The method may include depositing the hydrogel on a substrate. The hydrogel may include a three-dimensional network of polymer chains and at least a first type and a second type of functional groups coupled to the polymer chains. The method may include coupling an amplification primer to a first functional group of the deposited hydrogel. The method may include reversibly stabilizing the deposited hydrogel by reversibly cross-linking the amplification primer to a second functional group of the deposited hydrogel thereon.
[0011] Some examples herein provide another method of using a hydrogel. The method may include depositing the hydrogel on a substrate. The hydrogel may include a three-dimensional network of polymer chains, amplification primers coupled to the polymer chains, and functional groups coupled to the polymer chains. The method may include reversibly stabilizing the hydrogel by reversibly cross-linking the amplification primers coupled to the functional groups of the deposited hydrogel thereon.
[0012] Some examples herein provide another method of using a hydrogel. The method may include depositing a hydrogel on a substrate, the hydrogel including a three-dimensional network of polymer chains and a first functional group coupled to the polymer chains. The method may include coupling an amplification primer to a first subset of the first functional groups of the deposited hydrogel. The method may include converting a second subset of the first functional groups to a second functional group. The method may include reversibly stabilizing the hydrogel by reversibly crosslinking the second functional group.
[0013] Some examples herein provide another method of using a hydrogel. The method may include hybridizing a target polynucleotide with an amplification primer coupled to a hydrogel. The method may include cleaving crosslinks within a hydrogel in which the target polynucleotide is hybridized with the amplification primer. The method may include amplifying the target polynucleotide using additional amplification primers within a hydrogel in which the crosslinks have been cleaved. Optionally, the method may also include swelling the hydrogel after cleavage and before amplification.
[0014] It should be understood that any corresponding features / examples of each of the aspects of the present disclosure as described herein may be implemented together in any appropriate combination, and any features / examples from any one or more of these aspects may be implemented together with any of the features of the other (multiple) aspects as described herein in any appropriate combination to achieve the benefits as described herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figures 1A to 1F Exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated.
[0016] FIG. 2A to FIG. 2C Alternative exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated.
[0017] Figure 3 Another alternative exemplary composition and operation in a process flow for cluster amplification using a reversibly cross-linked hydrogel is schematically illustrated.
[0018] Figure 4 Exemplary hydrogels and exemplary cross-linking agents that can be used with such hydrogels are schematically illustrated.
[0019] FIG. 5A to FIG. 5B Additional exemplary hydrogels and exemplary cross-linking agents that can be used with such hydrogels are schematically illustrated.
[0020] Figure 6 Exemplary cleavable molecules that can be used to reversibly crosslink a hydrogel in a manner such as described herein are schematically illustrated.
[0021] Figure 7Additional exemplary cleavable molecules that can be used to reversibly crosslink a hydrogel in a manner such as described herein are schematically illustrated.
[0022] FIG. 8A to FIG. 8B Additional exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated.
[0023] FIG. 9A to FIG. 9B Additional exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated. DETAILED DESCRIPTION
[0024] Examples provided herein relate to reversibly cross-linked hydrogels, and methods of using the same for cluster amplification.
[0025] It may be desirable to use a functionalized hydrogel to perform sequencing by synthesis (SBS) in a flow cell to determine the sequence of the target polynucleotide in the corresponding cluster. For example, the hydrogel may include an amplification primer that can be coupled to a functional group thereon. The hydrogel may then be inoculated by allowing the target polynucleotide to flow through the flow cell, and an adapter that is complementary to the amplification primer and hybridized with a primer in the primer has been coupled to the target polynucleotide. The amplification primer in the hydrogel may then be used to amplify the seed, producing a cluster of multiple amplicons comprising the target polynucleotide (which may then be sequenced using SBS).
[0026] However, some previously known hydrogels can degrade during transport or storage, which can cause their performance to deteriorate. For example, during transport or storage, the hydrogel can collapse irreversibly. As a result, the amplification primers within the hydrogel can be inaccessible during amplification, resulting in the generation of clusters that include fewer amplicons and, therefore, generating less signal during SBS than clusters formed using hydrogels that have not been so degraded. This can reduce the accuracy of sequencing reads.
[0027] It is expected that the reversibly cross-linked hydrogels provided herein are significantly more stable than previously known hydrogels (such as described above) during transportation and storage. More specifically, the hydrogels of the present invention can be cross-linked before transportation and storage. Cross-linking can reduce or inhibit the irreversible collapse of the hydrogel during transportation and storage, such as by limiting the mobility of the polymer chains to form strong interchain physical bonds and / or intrachain physical bonds, in other words, by limiting the mobility of the polymer chains to rearrange to a lower entropy state, which will be unfavorably reversed in energy when rehydrated. Cross-linking can be controllably reversed, such as by applying a suitable stimulus to cleave or remove, and the hydrogel can then be used as needed.
[0028] Additionally, in some examples, the inoculation process can be performed before reversing the crosslinking bonds. Therefore, during the inoculation process, the amplification primers in the hydrogel may be relatively inaccessible, while the amplification primers at the exposed surface of the hydrogel can be used for inoculation. In some examples, the crosslinking can then be reversed so that the amplification primers in the hydrogel can be approached for amplification. Using the reversible crosslinking of the present invention to reduce the number of amplification primers that can be used for inoculation can reduce the number (or density) of inoculation events that occur, and therefore can improve the monoclonality of the clusters formed later than the hydrogels that are not crosslinked during inoculation. Additionally, using the reversible crosslinking of the present invention to subsequently increase the number of amplification primers that can be used for amplification can generate more amplicons than the hydrogels that have collapsed irreversibly due to their not yet crosslinked. Therefore, it can be understood that compared with previously known hydrogels, it can be expected that the reversibly crosslinked hydrogel of the present invention provides clusters with enhanced monoclonality and enhanced amplification. However, it should be understood that crosslinking can be used at any suitable time, for example, can be used to improve the stability of the hydrogels during transportation and storage and can be reversed before inoculation, and does not have to be used to adjust the accessibility of the amplification primers during inoculation and / or amplification.
[0029] First, some of the terms used herein will be briefly explained. Then, some exemplary methods of reversibly crosslinking hydrogels, resulting compositions, and methods of using reversibly crosslinked hydrogels will be described.
[0030] the term
[0031] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. The use of the term "comprising" and other forms such as "including" is not restrictive. The use of the term "having" is not restrictive. As used in this specification, whether in a transitional phrase or in the body of the claims, the terms "comprising" and "including" are to be interpreted as having an open-ended meaning. That is, the above terms should be interpreted synonymously with the phrases "at least having" or "at least including". For example, when used in the context of a process, the term "comprising" means that the process includes at least the listed steps, but may also include additional steps. When used in the context of a compound, composition, or device, the term "comprising" means that the compound, composition, or device includes at least the listed features or components, but may also include additional features or components.
[0032] The terms "substantially", "approximately", and "about" used throughout this specification are used to describe and account for minor fluctuations, such as due to variations in processing. For example, they may mean less than or equal to ±10%, such as less than or equal to ±5%, such as less than or equal to ±2%, such as less than or equal to ±1%, such as less than or equal to ±0.5%, such as less than or equal to ±0.2%, such as less than or equal to ±0.1%, such as less than or equal to ±0.05%.
[0033] As used herein, "hybridization" is intended to mean the non-covalent association of a first polynucleotide to a second polynucleotide along the length of those polynucleotides to form a double-stranded "duplex". For example, two DNA polynucleotide chains can associate through complementary base pairing. The strength of the association between the first and second polynucleotides increases with the complementarity between the nucleotide sequences within those polynucleotides. The strength of hybridization between polynucleotides can be characterized by the melting temperature (Tm), at which 50% of the duplexes have the polynucleotide chains dissociated from each other.
[0034] As used herein, the term "nucleotide" is intended to mean a molecule comprising a sugar and at least one phosphate group, and in some examples, a nucleobase. Nucleotides lacking a nucleobase may be referred to as "abasic". Nucleotides include deoxyribonucleotides, modified deoxyribonucleotides, ribonucleotides, modified ribonucleotides, peptide nucleotides, modified peptide nucleotides, modified phosphate sugar backbone nucleotides, and mixtures thereof. Examples of nucleotides include adenosine monophosphate (AMP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), thymidine monophosphate (TMP), thymidine diphosphate (TDP), thymidine triphosphate (TTP), cytidine monophosphate (CMP), cytidine diphosphate (CDP), cytidine triphosphate (CTP), guanosine monophosphate (GMP), guanosine diphosphate (GDP), guanosine triphosphate (GTP), uridine monophosphate (UMP), uridine diphosphate (UDP), uridine triphosphate (UTP), deoxyadenosine monophosphate (dAMP ), deoxyadenosine diphosphate (dADP), deoxyadenosine triphosphate (dATP), deoxythymidine monophosphate (dTMP), deoxythymidine diphosphate (dTDP), deoxythymidine triphosphate (dTTP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP), deoxyguanosine monophosphate (dGMP), deoxyguanosine diphosphate (dGDP), deoxyguanosine triphosphate (dGTP), deoxyuridine monophosphate (dUMP), deoxyuridine diphosphate (dUDP), and deoxyuridine triphosphate (dUTP).
[0035] As used herein, the term "nucleotide" is also intended to encompass any nucleotide analogs, which are nucleotides comprising a modified nucleobase, sugar, and / or phosphate moiety compared to a naturally occurring nucleotide. Exemplary modified nucleobases include inosine, xanthine (xathanine), hypoxanthine, isocytosine, isoguanine, 2-aminopurine, 5-methylcytosine, 5-hydroxymethylcytosine, 2-aminoadenine, 6-methyladenine, 6-methylguanine, 2-propylguanine, 2-propyladenine, 2-thiouracil, 2-thiothymine, 2-thiocytosine, 15-halouracil, 15-halocytosine, 5-propynyluracil, 5-propynylcytosine, 6-azouracil, In some embodiments, the nucleotide analogs of the present invention can be substituted with 5'- 5'- pyrimidine, 6-azocytosine, 6-azothymine, 5-uracil, 4-thiouracil, 8-halogenated adenine or guanine, 8-aminoadenine or guanine, 8-thiol adenine or guanine, 8-sulfanyl adenine or guanine, 8-hydroxyadenine or guanine, 5-halogenated uracil or cytosine, 7-methylguanine, 7-methyladenine, 8-azaguanine, 8-azaadenine, 7-deazaguanine, 7-deazaadenine, 3-deazaguanine, 3-deazaadenine, etc. As known in the art, some nucleotide analogs cannot be incorporated into polynucleotides, for example, nucleotide analogs such as 5'-phosphosulfate adenosine. Nucleotide can include any suitable number of phosphates, for example, three, four, five, six or more than six phosphates.
[0036] As used herein, the term "polynucleotide" refers to a molecule comprising a sequence of nucleotides bound to each other. Examples of polynucleotides include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and their analogs. A polynucleotide can be a single-stranded sequence of nucleotides, such as RNA or single-stranded DNA; a double-stranded sequence of nucleotides, such as double-stranded DNA; or a mixture of single-stranded and double-stranded sequences of nucleotides can be included. Double-stranded DNA (dsDNA) includes genomic DNA, as well as PCR and amplification products. Single-stranded DNA (ssDNA) can be converted to dsDNA and vice versa. A polynucleotide can include non-naturally occurring DNA, such as enantiomeric DNA. The precise sequence of nucleotides in a polynucleotide may be known or unknown. The following are examples of polynucleotides: a gene or gene fragment (e.g., a probe, a primer, an expressed sequence tag (EST) or a serial analysis of gene expression (SAGE) tag), genomic DNA, a genomic DNA fragment, an exon, an intron, messenger RNA (mRNA), transfer RNA, ribosomal RNA, a ribozyme, cDNA, a recombinant polynucleotide, a synthetic polynucleotide, a branched polynucleotide, a plasmid, a vector, an isolated DNA of any sequence, an isolated RNA of any sequence, a nucleic acid probe, a primer, or an amplified copy of any of the foregoing.
[0037] As used herein, "polymerase" is intended to mean an enzyme with an active site for assembling polynucleotides by polymerizing nucleotides into polynucleotides. Polymerases can bind to the single-stranded target polynucleotides initiated, and nucleotides can be sequentially added to the growing primer to form a "complementary replication" polynucleotide having a sequence complementary to the sequence of the target polynucleotide. Then, another polymerase or the same polymerase can form a copy of the target nucleotide by forming a complementary copy of the complementary replication polynucleotide. Any of such copies may be referred to as "amplicon" herein. DNA polymerases can be bound to the target polynucleotides and then move down along the target polynucleotides, adding nucleotides sequentially to the free hydroxyl groups at the 3' end of the growing polynucleotide chain (growing amplicon). DNA polymerases can synthesize complementary DNA molecules from DNA templates and RNA polymerases can synthesize RNA molecules (transcription) from DNA templates. Polymerases can use short RNA or DNA chains (primers) to start chain growth. Some polymerases can cause them to add bases to the chain site upstream of the chain to shift. Such polymerases can be referred to as chain shifts, meaning that they have the activity of removing complementary chains from the template chain read by the polymerase. Exemplary polymerases with strand translocation activity include, but are not limited to, Bacillus stearothermophilus (Bst) polymerase, exo-Klenow polymerase, or large fragments of sequencing grade T7 exo-polymerase. Some polymerases degrade the strand in front of them, effectively replacing the strand in front with the strand growing behind (5' exonuclease activity). Some polymerases have activity that degrades the strand behind them (3' exonuclease activity). Some useful polymerases have been modified by mutation or otherwise to reduce or eliminate 3' and / or 5' exonuclease activity.
[0038] As used herein, the term "primer" is defined as a polynucleotide to which nucleotides can be added by free 3'OH groups. Primers may include 3' blocking groups that can prevent polymerization until the blocking groups are removed. Primers may include modifications at the 5' end to allow coupling reactions or to couple the primer to another part. Primers may include one or more parts that may be cleaved under suitable conditions (such as UV light, chemistry, enzymes, etc.). Primer length may be the length of any suitable number of bases, and may include any suitable combination of natural and non-natural nucleotides. Target polynucleotides may include "adapters", which may hybridize with primers (having sequences complementary to primers), and may be amplified so as to generate complementary replication polynucleotides by adding nucleotides to the free 3'OH groups of primers. "Amplification primers" are intended to represent primers that are coupled to substrates and may hybridize with the second adapter of target polynucleotides, while "orthogonal amplification primers" are intended to represent primers that are coupled to substrates and may hybridize with the first adapter of the target polynucleotides. The first adapter may have a sequence complementary to the sequence of the orthogonal amplification primer, and the second adapter may have a sequence complementary to the sequence of the amplification primer. The amplification primer and the orthogonal amplification primer may have sequences that are different and independent from each other. In a non-limiting example, the amplification primer includes a P5 primer, and the orthogonal amplification primer includes a P7 primer.
[0039] As used herein, the term "substrate" refers to a material used as a support for a composition described herein. Exemplary substrate materials may include glass, silicon dioxide, plastic, quartz, metal, metal oxide, organosilicate (e.g., polyhedral organosiliconesquioxane (POSS)), polyacrylate, tantalum oxide, complementary metal oxide semiconductor (CMOS), or a combination thereof. The example of POSS may be the POSS described in Kehagias et al., Microelectronic Engineering, 86 (2009), pp. 776-778, which is incorporated herein by reference in its entirety. In some examples, the substrate used in the present application includes a silicon dioxide-based substrate, such as glass, fused silica, or other silicon dioxide-containing materials. In some examples, the substrate may include silicon, silicon nitride, or hydrogenated silicone. In some examples, the substrate used in the present application includes a plastic material or component, such as polyethylene, polystyrene, poly(vinyl chloride), polypropylene, nylon, polyester, polycarbonate, and poly(methyl methacrylate). Exemplary plastic materials include poly(methyl methacrylate), polystyrene, and cycloolefin polymer substrates. In some examples, the substrate is or includes a silicon dioxide material or a plastic material or a combination thereof. In a specific example, the substrate has at least one surface including glass or a silicon-based polymer. In some examples, the substrate may include a metal. In some such examples, the metal is gold. In some examples, the substrate has at least one surface including a metal oxide. In one example, the surface includes tantalum oxide or tin oxide. Acrylamide, enone, or acrylate may also be used as a substrate material or component. Other substrate materials may include but are not limited to gallium arsenide, indium phosphide, aluminum, ceramics, polyimide, quartz, resins, polymers, and copolymers. In some examples, the substrate and / or the substrate surface may be or include quartz. In some other examples, the substrate and / or the substrate surface may be or include a semiconductor such as GaAs or ITO. The foregoing list is intended to illustrate but is not limited to the present application. The substrate may include a single material or a plurality of different materials. The substrate may be a composite or a laminate. In some examples, the substrate includes an organosilicate material. The substrate may be flat, round, spherical, rod-shaped, or any other suitable shape. The substrate may be rigid or flexible. In some examples, the substrate is a bead or a flow cell.
[0040] In some examples, the substrate comprises a patterned surface. "Patterned surface" refers to the arrangement of different regions in or on the exposed layer of the substrate. For example, one or more regions may be features in which one or more amplification primers are present, such as in a hydrogel within the feature. Features may be separated by gap regions where there are no amplification primers and hydrogel. In some examples, the pattern may be features in the form of xy in rows and columns. In some examples, the pattern may be features and / or gap regions that are repeatedly arranged. In some examples, the pattern may be features and / or gap regions that are randomly arranged. In some examples, the substrate comprises an array of holes (depressions) in the surface. The hole may be provided by substantially vertical sidewalls. The hole may be manufactured using a variety of techniques as generally known in the art, including but not limited to photolithography, imprinting technology, molding technology, and micro-etching technology. Those skilled in the art will appreciate that the technology used will depend on the composition and shape of the array substrate.
[0041] The features in the patterned surface of the substrate can include holes (e.g., micropores or nanopores) in a hole array on glass, silicon, plastic, or other suitable materials with patterned hydrogels such as provided herein. Patterning can provide a hydrogel pad that can be used for sequencing, such as the hydrogel pad can be stable in a sequencing run with a large number of cycles. In some examples, the covalent attachment of the hydrogel to the hole can help maintain the hydrogel in the structured features (e.g., hole) during the entire life of the structured substrate during multiple uses. However, in some examples, the hydrogel does not need to be covalently attached to the hole.
[0042] In a specific example, the structured substrate can be prepared by the following method: a substrate formed by a suitable material is patterned to have holes (e.g., micropores or nanopores), the substrate material is coated with a hydrogel, and the surface of the material coated with the hydrogel is polished, for example, via chemical or mechanical polishing, so that the hydrogel is kept in the hole, but substantially all of the hydrogel is removed from the gap area on the surface of the structured substrate between the holes or substantially all of the hydrogel is inactivated. Amplification primers can be attached to the hydrogel, for example, in a manner such as provided herein. A solution including a variety of target polynucleotides (e.g., a fragmented human genome or a portion thereof) can then be contacted with the polished substrate so that individual target polynucleotides will be inoculated to individual holes via interactions with amplification primers attached to the hydrogel; however, since there is no hydrogel or the hydrogel is inactive, the target polynucleotide will not occupy the gap area. Because there is no hydrogel or the hydrogel is inactive in the gap area, the outward migration of the growth cluster can be inhibited, so the amplification of the target polynucleotide can be limited to the hole. The process can be conveniently manufactured, scalable, and utilizes conventional micro or nano manufacturing methods.
[0043] Patterned substrates may include holes, for example, etched into a slide or chip. The pattern and geometry of the etching of the holes may be in a variety of different shapes and sizes, and such features may be physically or functionally separated from each other. Particularly useful substrates with such structural features include patterned substrates that can select the size of solid particles such as microspheres. An example patterned substrate with these characteristics is an etched substrate used in conjunction with bead array technology (Illumina, Inc., San Diego, Calif.).
[0044] In some examples, the substrate described herein forms at least a portion of a flow cell, is located in a flow cell, or is coupled to a flow cell. The flow cell may include a flow chamber divided into a plurality of lanes or a plurality of partitions. Exemplary flow cells that can be used in the methods and compositions described herein and substrates for making flow cells include but are not limited to those available from Illumina, Inc. (San Diego, California).
[0045] As used herein, when used with reference to a layer covering a surface of a substrate, the term "directly" is intended to mean that the layer covers the surface of the substrate without an obvious intermediate layer, such as an adhesive layer or a polymer layer. The layer directly covering the surface can be attached to the surface by any chemical or physical interaction, including covalent bonds or non-covalent adhesion.
[0046] As used herein, when used with reference to polynucleotides, the term "fixed" is intended to mean directly or indirectly attached to a substrate by covalent or non-covalent bonds. In some examples, covalent attachment or any other suitable attachment may be used, wherein the polynucleotide remains fixed or attached to a substrate under conditions intended to use the substrate (e.g., in polynucleotide amplification or sequencing). The polynucleotide to be used as an amplification primer or as a target polynucleotide may be fixed so that the 3'-end can be used for enzymatic extension, and at least a portion of the sequence can hybridize with a complementary sequence. Fixation may occur by hybridization with oligonucleotides attached to a surface, in which case the fixed oligonucleotide or polynucleotide may be in a 3'-5' orientation. Alternatively, fixation may occur by means other than base pairing hybridization (such as covalent attachment).
[0047] As used herein, the term "array" refers to a group of substrate regions that can be distinguished from each other according to relative positions. Different molecules (such as polynucleotides) located at different regions of the array can be distinguished from each other according to the positions of these regions in the array. A single region of an array may include one or more specific types of molecules. For example, a substrate region may include a single target polynucleotide with a specific sequence, or a substrate region may include several polynucleotides with the same sequence (or its complementary sequence). The regions of the array may include different features on the same substrate, respectively. Exemplary features include, but are not limited to, holes in substrates, beads (or other particles) in or on substrates, protrusions of substrates, ridges on substrates, or channels in substrates. The regions of the array may include different regions on substrates that are different from each other, respectively. Different molecules attached to a separate substrate can be identified according to the position of the substrate on a surface associated with the substrate, or according to the position of the substrate in a liquid or gel. Exemplary arrays in which separate substrates are located on the surface include, but are not limited to, those arrays with beads in holes.
[0048] As used herein, the term "plurality" is intended to mean a population of two or more different members. The plurality may range in size from small, medium, large to extremely large. The size of a small plurality may range, for example, from a few members to tens of members. A medium-sized plurality may range, for example, from tens of members to about 100 members or hundreds of members. A large plurality may range, for example, from about hundreds of members to about 1000 members, to thousands of members, and up to tens of thousands of members. An extremely large plurality may range, for example, from tens of thousands of members to about hundreds of thousands, one million, several million, tens of millions, and up to or exceeding hundreds of millions of members. Thus, the plurality may range from two to well over 100 million members and all sizes as measured by the number of members, between the above exemplary ranges, and beyond the above exemplary ranges. Exemplary polynucleotide plurality includes, for example, about 1×10 5 or more, 5×10 5 or more, or 1×10 6 or more different polynucleotide populations. Thus, the definition of the term is intended to include all integer values greater than two. The upper limit of the plurality of numbers can be set, for example, by the theoretical diversity of the polynucleotide sequences in the sample.
[0049] As used herein, the term "double-stranded" when used with reference to a polynucleotide is intended to mean that all or substantially all of the nucleotides in the polynucleotide are hydrogen bonded to corresponding nucleotides in a complementary polynucleotide.
[0050] As used herein, the term "single-stranded" when used with reference to a polynucleotide means that substantially none of the nucleotides in the polynucleotide are hydrogen bonded to corresponding nucleotides in a complementary polynucleotide.
[0051] As used herein, the term "target polynucleotide" is intended to mean a polynucleotide that is an object of analysis or action. The analysis or action includes subjecting the polynucleotide to amplification, sequencing, and / or other procedures. The target polynucleotide may include a nucleotide sequence other than the target sequence to be analyzed. For example, the target polynucleotide may include one or more adapters, including adapters that act as primer binding sites, and the adapters flank the target polynucleotide sequence to be analyzed. The target polynucleotide hybridized with the amplification primer may include nucleotides that extend beyond the 5' end or 3' end of the amplification primer in a manner that not all target polynucleotides are easy to extend. In a specific example, the target polynucleotide may have sequences that are different from each other, but may have a first adapter and a second adapter that are identical to each other. Two adapters that may be located on the flanks of a specific target polynucleotide sequence may have sequences that are identical to each other, or sequences that are complementary to each other, or the two adapters may have different sequences. Therefore, the species in a plurality of target polynucleotides may include a region of known sequence, which is located on the flanks of an unknown sequence region that will be evaluated by, for example, sequencing (e.g., SBS). In some examples, the target polynucleotide carries an adaptor at a single end, and such adaptor may be located at the 3' end or the 5' end of the target polynucleotide. The target polynucleotide may be used without any adaptor, in which case the primer binding sequence may be derived directly from a sequence found in the target polynucleotide.
[0052] The terms "polynucleotide" and "oligonucleotide" are used interchangeably herein. Unless specifically indicated otherwise, the different terms are not intended to represent any specific differences in size, sequence, or other properties. For clarity of description, when describing a specific method or composition comprising several polynucleotide species, the terms may be used to distinguish one polynucleotide species from another species.
[0053] As used herein, the term "amplicon" when used with respect to a polynucleotide is intended to mean a product of a replicated polynucleotide, wherein the product has a nucleotide sequence that is substantially identical to at least a portion of the nucleotide sequence of the polynucleotide or substantially complementary to at least a portion of the nucleotide sequence of the polynucleotide. "Amplification" refers to the process of making an amplicon of a polynucleotide. The first amplicon of a target polynucleotide can be a complementary duplicate. Additional amplicons are duplicates produced from the target polynucleotide or from the first amplicon after the first amplicon is produced. Subsequent amplicons can have sequences that are substantially complementary to the target polynucleotide or substantially consistent with the target polynucleotide. It should be understood that when an amplicon of a polynucleotide is produced, a small amount of mutations of the polynucleotide (e.g., due to amplification artifacts) may occur.
[0054] As used herein, "hydrogel" refers to a three-dimensional polymer network structure including polymer chains and at least partially hydrophilic and containing water in the space between polymer chains. Hydrogels may include any suitable combination of hydrophilic, hydrophobic and / or amphiphilic polymers, as long as the entire polymer network is hydrophilic and contains water in the space between polymer chains. Hydrogels include chemical hydrogels, in which the bonds forming the polymer chains and any crosslinking between the polymer chains are covalent; unlike the reversible crosslinking of the present invention performed after the hydrogel is formed, such crosslinking during the formation of the hydrogel may be irreversible. In some cases, the chemical hydrogel may include or may be substantially composed of the following items: a brush-like structure of polymer chains attached to the surface (basically no physical or covalent crosslinking between polymer chains), or an alternative polymer chain with multiple attachment points attached to the surface (producing a ring, but also lacking interchain crosslinking). Hydrogels also include physical hydrogels, in which the bonds forming the polymer chains and any crosslinking within the polymer chains are not covalent. Non-limiting examples of physical hydrogels include agarose and alginate.
[0055] As used herein, the "polymer chains" of a hydrogel are intended to represent those parts of a hydrogel that are polymerized with each other during a polymerization process. The polymer chains may be cross-linked to form a hydrogel. For example, a cross-linking agent may be added during or after the polymerization process to form the polymer chains. Additionally or alternatively, in some examples, the polymer chains may be deposited on a substrate surface including a functional group to which the functional group of the polymer chain is coupled. The polymer chains may be coupled to the surface, for example, via a reaction between the functional group of the polymer chain and the functional group at the surface, and such coupling may cross-link the polymer chains to form a hydrogel. Such cross-linking may cause the polymer chains to be covalently or non-covalently attached to each other, or may occur due to chain entanglement during polymerization and / or attachment to the surface. As provided herein, the polymer chains may also or alternatively be reversibly cross-linked after the hydrogel is formed, for example, using functional groups in a manner such as described in more detail below.
[0056] As used herein, the term "functional group" is intended to mean a chemical entity that reacts with another chemical entity of the same type or a different type to form a covalent or non-covalent bond. As provided herein, when a hydrogel is described as having a functional group, it is understood that the functional group is chemically distinct from the polymer chain. Thus, during the formation of the hydrogel or the attachment of the polymer chains to the surface, the functional group may not necessarily participate in forming a three-dimensional network of polymer chains; therefore, and as provided herein, the functional group may be used for additional crosslinking of the hydrogel after the hydrogel itself is formed and disposed on a substrate.
[0057] Methods of forming and using reversibly cross-linked hydrogels
[0058] As provided herein, the stability of the hydrogel can be enhanced by reversibly cross-linking the hydrogel, for example, after the hydrogel is formed (after the formation and cross-linking of the polymer chains to form the hydrogel is completed) and before the hydrogel is transported and / or stored. Additionally or alternatively, as provided herein, the hydrogel can be reversibly cross-linked at any suitable time before the hydrogel is seeded with the template polynucleotide, and the cross-linking bonds can be reversed at any suitable time before or during cluster amplification using the seeded template polynucleotide. Alternatively, the cross-linking bonds can be reversed before seeding.
[0059] For example, Figures 1A to 1F Exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated. Figure 1A The composition illustrated in includes a hydrogel 100 on a substrate 140. Optionally, the substrate 140 may include vertical sidewalls 150 that laterally constrain the hydrogel 100. The hydrogel 100 includes a three-dimensional network of polymer chains 110, intended to be represented by elongated lines that intersect each other. The hydrogel 100 also includes a first functional group 120 coupled to the polymer chain 110, and a second functional group 130 coupled to the polymer chain 110. Figure 1AIn the illustrated non-limiting example, the first functional group 120 and the second functional group 130 are chemical entities of different types from each other, and are chemical entities of different types from the monomers forming the polymer chains 110 of the hydrogel 100. The first functional groups 120 may be the same as each other, or may be different from each other. The second functional groups 130 may be the same as each other, or may be different from each other. The hydrogel 100 may be formed in any suitable manner to form a three-dimensional cross-linked network of polymer chains 110 including the first functional group 120 and the second functional group 130. Non-limiting examples of monomers that can be used to form the hydrogel 100 will be described in more detail below. In some examples, the hydrogel 100 is a chemical hydrogel in which both the bonds and cross-links within the polymer chains 110 of the hydrogel are covalent and therefore irreversible. The first functional group 120 and the second functional group 130 do not substantially participate in the formation of the polymer chains 110 of the hydrogel 100, or do not substantially participate in the cross-linking of such polymer chains during the formation of the hydrogel 100. In contrast, in a manner such as will be described in more detail below, the first functional groups 120 can be used to couple the amplification primers to the polymer chains 110 after the hydrogel 100 is formed, and the second functional groups 130 can be used to crosslink the polymer chains 110 to each other after the amplification primers are coupled to the polymer chains. The polymer chains 110 and / or the substrate 140 can include other functional groups (not specifically shown) via which the polymer chains can be crosslinked to each other and / or to the substrate 140 during the formation of the hydrogel 100. Such functional groups, and such crosslinks during the formation of the hydrogel, are different from the functional groups 130 used to reversibly crosslink the hydrogel after the hydrogel is formed (e.g., minutes, hours, days, or longer after the hydrogel is formed).
[0060] Figure 1A The hydrogel 100 illustrated in FIG. 1 can be contacted with a fluid including an amplification primer, which includes a functional group (not specifically illustrated) configured to react with the first functional group 120 to covalently bind the amplification primer to the polymer chain 110. During such contact between the fluid and the hydrogel 100, the amplification primers 121, 122 can diffuse through the open spaces within the three-dimensional cross-linked network of the hydrogel, and thus can be covalently coupled to the polymer chain 110 at a variety of different lateral positions and a variety of different depths, such as for example, Figure 1B For example, the hydrogel 100 may have a sufficient amount of open space to facilitate diffusion of the amplification primers 121, 122 therethrough. Figure 1A Such contact between the fluid and the hydrogel 100 forms Figure 1B The modified hydrogel 101 illustrated in FIG. 1 includes amplification primers 121 and 122 coupled to the polymer chain 110 via a first functional group 120. Figure 1BIn FIG. 1 , the first functional group 120 is indicated by being filled in black, and the reference numeral 120′ indicates that the functional group has reacted with the functional groups of the amplification primers 121 and 122. Figure 1B In the embodiment, amplification primers 121, 122 are illustrated as having different fills from each other to represent a non-limiting example in which different types of amplification primers are coupled to the hydrogel. For example, amplification primer 121 may include a P5 primer, and amplification primer 122 may include an orthogonal amplification primer, such as a P7 primer.
[0061] Figure 1B The hydrogel 101 illustrated in FIG. 1 can be contacted with a fluid including at least one chemical or enzyme agent that is configured to react with the second functional groups 130 such that such functional groups covalently or non-covalently cross-link the polymer chains 110 of the hydrogel 101 to each other. During such contact between the fluid and the hydrogel 101, the at least one chemical or enzyme agent can diffuse through the open spaces within the three-dimensional cross-linked network of the hydrogel 101 and can cross-link the polymer chains 110 at a variety of different lateral locations and a variety of different depths, such as to Figure 1C The open spaces within the hydrogel 101 can facilitate diffusion of at least one chemical or enzyme agent therethrough. Such contact forms Figure 1C The modified hydrogel 102 illustrated in FIG. 1 , wherein the second functional group 130 coupled to the polymer chain 110 reversibly cross-links the polymer chains to each other. Figure 1C In FIG. 1 , the second functional group 130 is indicated by black filling, and the reference numeral 130′ indicates that the functional group has reacted to crosslink the polymer chains. Figure 1C , cross-links 131 between polymer chains 110 are illustrated using dashed lines to indicate that such cross-links are reversible, for example, in a manner such as will be described in more detail below.
[0062] As such Figure 1C As a result of the cross-linking illustrated in FIG. 1 , hydrogel 102 may have an open space percentage that is significantly less than the open space percentage of hydrogel 100 and significantly less than the open space percentage of hydrogel 101, as intended by Figure 1C The reduced open space of hydrogel 102, compared to the open space of hydrogels 100 and 101, can reduce or inhibit the diffusion of any agent therethrough, for example, as shown in reference Figure 1DIn the manner described. Additionally, crosslinks 131 within hydrogel 102 can be expected to significantly stabilize hydrogel 102, such as during storage or transportation, compared to hydrogels 100 and 101. Illustratively, if hydrogel 100 or 101 is shipped or stored under conditions that cause the hydrogel to completely or partially dry out (lose water), the resulting reduction in the distance between polymer chains 110 can cause the polymer chains to irreversibly hydrogen bond to each other in such a manner that the hydrogel is irreversibly collapsed, thereby closing a significant portion of the open space in the hydrogel. Therefore, even if water is added to the collapsed hydrogel, the water may not significantly penetrate into the collapsed hydrogel, and the hydrogel may remain in the collapsed state, which has at most limited utility for further use. In contrast, crosslinks 131 within hydrogel 102 can keep polymer chains 110 spaced apart from each other at a sufficient distance to inhibit such irreversible hydrogen bonding, and therefore to inhibit irreversible collapse of the hydrogel. Thus, when the cross-linking is reversed, such as in a manner described below, the hydrogel can swell back to an open state, wherein water and agents can once again diffuse into the hydrogel.
[0063] Additionally, the reduced open space of hydrogel 102 can optionally be used to improve the monoclonality of clusters generated using hydrogel 102 compared to clusters generated using hydrogel 101. For example, Figure 1CThe hydrogel 102 illustrated in the embodiment of the present invention can optionally be contacted with a fluid including a target polynucleotide 160, the target polynucleotide including a first adapter and a second adapter (not specifically illustrated) that are complementary to the amplification primers 121, 122, respectively. During such contact between the fluid and the hydrogel 102, the reduced open space within the three-dimensional cross-linked network of the hydrogel 102 can reduce or inhibit the diffusion of the target polynucleotide 160 into the hydrogel 102 compared to the diffusion within the hydrogel 101. As a result of the reduced open space within the hydrogel 102, the number of amplification primers 121, 122 that can be used for hybridization of the target polynucleotide 160 can be significantly lower than the total number of amplification primers 121, 122 within the hydrogel 102. In fact, in some examples, the crosslinks 131 within the hydrogel 102 reduce the open space within the hydrogel 102 to the extent that the target polynucleotide 160 does not substantially diffuse into the hydrogel, and is therefore substantially limited to hybridizing with the amplification primers 121, 122 at the surface of the hydrogel. In contrast, if hydrogel 101 were to come into contact with the same fluid including target polynucleotide 160, it is expected that the target polynucleotide would readily diffuse into the hydrogel and hybridize with amplification primers 121, 122 at a variety of different lateral positions and at a variety of different depths. Because the number of amplification primers available for hybridization with target polynucleotide 160 is significantly reduced in hydrogel 102 compared to hydrogel 101, the likelihood that hydrogel 102 will have only a single hybridization event (single seeding event) is significantly greater than that of hydrogel 101. Therefore, it can be expected that clusters generated using hydrogel 102 are significantly more likely to be monoclonal than clusters generated using hydrogel 101. Illustratively, in Figure 1D In the example shown in , the hydrogel 103 includes only a single target polynucleotide 160 that hybridizes to the amplification primer 131 at the surface of the hydrogel because the crosslinks 121 substantially reduce the availability of the amplification primer at a greater depth within the hydrogel for such hybridization.
[0064] exist Figure 1D In the non-limiting example shown in FIG. 1 , after the target polynucleotide 160 is hybridized with the amplification primer 121, the crosslinks 131 between the second functional groups 130' can be reversed. Figure 1D The hydrogel 103 illustrated in the embodiment of the present invention can be contacted with a fluid including at least one chemical agent or an enzyme agent that is configured to react with the cross-links 131 to reverse the covalent or non-covalent cross-links between the polymer chains 110. During such contact between the fluid and the hydrogel 103, the at least one chemical agent or enzyme agent can diffuse through the open spaces within the three-dimensional cross-linked network of the hydrogel 103 and can reverse the cross-links 131 between the polymer chains 110 at a variety of different lateral locations and a variety of different depths, such as to reverse the cross-links 131 between the polymer chains 110. Figure 1E Note that upon initial contact with such a fluid, the hydrogel 103 may be, for example, Figure 1DThe manner described is substantially closed by crosslinks 131. However, a fluid may contact the surface of the hydrogel 103 and may reverse the crosslinks at the surface, which may cause the hydrogel to open at the surface. Such opening may allow the fluid to diffuse slightly into the hydrogel and there reverse additional crosslinks, which may cause the hydrogel to open slightly below the surface. In such a manner, as the hydrogel gradually and directionally opens from its surface, the fluid may diffuse further into the hydrogel, ultimately leading to reopening of the entire hydrogel. The resulting open space may facilitate diffusion of at least one chemical agent or enzyme agent therethrough. Such contact forms Figure 1E 1 , wherein the cross-linking bonds using the second functional groups 130' are broken, as illustrated by the shortened dashed lines and reference numeral 131'.
[0065] In some examples, the target polynucleotide 160 hybridized to the amplification primer 121 can then be amplified, for example, using bridge amplification or other cluster generation techniques described elsewhere herein or otherwise known in the art. For example, the target polynucleotide 160 can be amplified using processes such as those known in the art, such as using surface-bound polymerase chain reaction (PCR), bridge amplification, or strand invasion method (which may be referred to as ExAmp), to form Figure 1F Such amplification processes may use chemical and / or enzymatic agents that diffuse through the open spaces within the three-dimensional cross-linked network of the hydrogel 104, resulting in the coupling of the amplicons 160' to the polymer chains 110 at a variety of different lateral locations and at a variety of different depths, such as to Figure 1F exemplified in . like Figure 1F As illustrated in , the amplicon 160' may be coupled directly to the polymer chain 110, such as via initially coupling the primers 121, 122 to the first functional group 120 of the polymer chain.
[0066] In some examples, the amount of open space within hydrogel 101 can be similar to the amount of open space within hydrogel 100, for example, within about 20%, or within about 10%, or within about 5% of the open space within hydrogel 100. Additionally or alternatively, in some examples, the crosslink density of hydrogel 101 can be similar to the crosslink density of hydrogel 100, for example, within about 20%, or within about 10%, or within about 5% of the crosslink density within hydrogel 100. Additionally or alternatively, in some examples, the amount of open space within hydrogel 103 can be similar to the amount of open space within hydrogel 102, for example, within about 20%, or within about 10%, or within about 5% of the open space within hydrogel 102. Additionally or alternatively, in some examples, the crosslink density of hydrogel 103 can be similar to the crosslink density of hydrogel 102, for example, within about 20%, or within about 10%, or within about 5% of the crosslink density within hydrogel 102. Additionally or alternatively, in some examples, the amount of open space within hydrogel 104 can be similar to the amount of open space within hydrogel 101, for example, can be within about 20%, or within about 10%, or within about 5% of the open space within hydrogel 101. Additionally or alternatively, in some examples, the crosslink density of hydrogel 104 can be similar to the crosslink density of hydrogel 101, for example, can be within about 20%, or within about 10%, or within about 5% of the crosslink density within hydrogel 101. Additionally or alternatively, in some examples, the amount of open space within hydrogel 105 can be similar to the amount of open space within hydrogel 101, for example, can be within about 20%, or within about 10%, or within about 5% of the open space within hydrogel 101. Additionally or alternatively, in some examples, the crosslink density of hydrogel 105 can be similar to the crosslink density of hydrogel 101, for example, can be within about 20%, or within about 10%, or within about 5% of the crosslink density in hydrogel 101. Additionally or alternatively, in some examples, the open space of hydrogel 102 or 103 can be significantly lower than the open space of hydrogel 100, hydrogel 101, hydrogel 104, and / or hydrogel 105, for example, can be less than about 80%, or less than about 60%, or less than about 40%, or less than about 20% of the open space in hydrogel 100, hydrogel 101, hydrogel 104, and / or hydrogel 105. Additionally or alternatively, in some examples, the crosslink density of hydrogel 102 or 103 can be significantly higher than the crosslink density of hydrogel 100, hydrogel 101, hydrogel 104, and / or hydrogel 105, for example, about 20%, or about 40%, or about 60%, or about 80% higher than the crosslink density within hydrogel 100, hydrogel 101, hydrogel 104, and / or hydrogel 105. Additionally or alternatively, in some examples, hydrogel 100, 101, 104, and / or 105 can have a thickness that is at least ten times greater than the thickness of hydrogel 102 and / or 103.For example, hydrogels 100 , 101 , 104 , and / or 105 may have a thickness of about 80 nm to 120 nm, while hydrogels 102 and / or 103 may have a thickness of about 8 nm to 12 nm.
[0067] The amount of open space and / or crosslink density in the hydrogel can be characterized using mechanical measurements, such as modulus determined from force-distance curves in wet atomic force microscopy (AFM). Additionally or alternatively, the amount of open space and / or crosslink density in the hydrogel can be measured by mesh size, for example, using small angle X-ray scattering (SAXS) or small angle neutron scattering (SANS). Additionally or alternatively, the amount of open space and / or crosslink density in the hydrogel can be characterized using swelling capacity (mass ratio between dry hydrogel and wet hydrogel), for example, using quartz crystal microbalance (QCM) or ellipsometry in the wet state compared to the dry state. Additionally or alternatively, the amount of open space and / or crosslink density in the hydrogel can be characterized using modulus (E' from nanoindentation), which is related to the hardness / softness of the hydrogel due to the crosslink density. For example, using nanoindentation, there is a difference between highly and less crosslinked hydrogels or polymers. Illustratively, an exemplary strategy to evaluate the openness of a hydrogel in its real conditions on the surface of a flow cell (e.g., which can be about 80nm to 120nm thick in a wet state and about 8nm to 12nm in a dry state) is to use fluorescent probes incorporated by hybridization or base. Ellipsometry can also or alternatively be used to detect swelling. QCM is also compatible with thin hydrogel layers for evaluating swelling, but in some examples, the hydrogel can be deposited on the QCM sensor rather than directly on the flow cell substrate. For relatively thin film hydrogels (e.g., <100nm thickness), nanoindentation can be used. QCM can be used to measure mass changes by water adsorption (open vs. closed) or by measuring primers bound within the hydrogel.
[0068] Additionally or alternatively, the amount of open space and / or crosslink density within a hydrogel (e.g., hydrogel 101, 102, 103, or 104) that includes amplification primers that can be used for hybridization can be characterized using surface charge. For example, crosslinking can obscure primers (which are negatively charged), thereby inhibiting the contribution of primers to surface charge. In some examples, the surface charge can be characterized using atomic force microscopy (AFM), for example by measuring the interaction between the surface and the AFM tip. Additionally or alternatively, Kelvin probe force microscopy can be used to characterize the surface charge of the hydrogel. Additionally or alternatively, electrokinetic analysis can be used to characterize the surface charge of the hydrogel at the solid-liquid interface. Additionally or alternatively, the amount of open space and / or crosslink density within a hydrogel (e.g., hydrogel 101, 102, 103, or 104) that includes amplification primers that can be hybridized can be characterized using complementary fluorescent oligonucleotide probes to hybridize with amplification primers within the hydrogel; the fluorescence intensity of the hybridization probe can be used to quantify the primers on the surface, and in the case of bulky probes such as hairpins, the fluorescence can indicate the accessibility of the surface primers to the template during the seeding event. Additionally or alternatively, the amount of open space and / or crosslink density within the hydrogel can be measured by quantifying cleaved bonds using infrared (IR) spectroscopy, for example, by comparing the intensity of the crosslinker signal in the open or cleaved state with the intensity of the crosslinker signal in the crosslinked state. Additionally or alternatively, the amount of open space and / or crosslink density within the hydrogel can be measured by viscosity, for example, by comparing the cleaved or open polymer viscosity with the fully crosslinked polymer viscosity. Additionally or alternatively, the amount of open space and / or crosslink density within the hydrogel can be measured by comparing the molecular weight of the hydrogel in the open or cleaved state with the molecular weight in the crosslinked state.
[0069] although Figures 1A to 1F The use of the first functional group 120 and the second functional group 130 of different types from each other is described, but it should be understood that the types of the first functional group and the second functional group may be the same as each other. For example, FIG. 2A to FIG. 2C Schematically illustrates alternative exemplary compositions and operations in a process flow for cluster amplification using a reversibly cross-linked hydrogel. Figure 2A As shown in FIG. 1 , the hydrogel 200 can be used in conjunction with the reference Figure 1A The hydrogel 200 may include a three-dimensional network of polymer chains 110 and first functional groups 120 coupled to the polymer chains. Figure 1B In a similar manner, amplification primers 121, 122 can be coupled to the first functional group 120 of the deposited hydrogel. Figure 2BAs illustrated in FIG. 1 , amplification primers 121, 122 may be coupled to a first subset of first functional groups 120 of the deposited hydrogel (such functional groups are indicated by dark shading and reference numeral 120' to indicate their reaction). A second subset of first functional groups 120 remains unreacted, producing Figure 2B The modified hydrogel 210 illustrated in FIG. 201 can then be converted to a second subset of the first functional groups 120 of the hydrogel 201, for example, in the form of a Figure 2C For example, one or more suitable chemical or enzyme reagents can be diffused into the hydrogel 201 to convert the second subset of the first functional groups 120 into the second functional groups 130, producing Figure 2C The hydrogel 202 exemplified in Figure 1B The hydrogel 101 is similarly constructed. The hydrogel 202 can then be stabilized by reversibly crosslinking the second functional groups 130, for example, with a method such as reference Figure 1C The resulting reversibly cross-linked hydrogel can then be used, for example, as described in Figures 1D to 1F Use in the manner described.
[0070] In another example, the hydrogel can be formed to include amplification primers. For example, Figure 3 Another alternative exemplary composition and operation in a process flow for cluster amplification using a reversibly cross-linked hydrogel is schematically illustrated. Figure 3 In the example shown in FIG. 1 , the hydrogel 300 can be Figure 1A and Figure 2B The hydrogel 300 may include a three-dimensional network of polymer chains 110 similar to the hydrogels 100 and 200. The hydrogel 300 may also include amplification primers 121, 122 coupled to the polymer chains 110. Illustratively, during the preparation of the hydrogel 300, for example, before the hydrogel is deposited on the substrate 140, the amplification primers may be coupled to the polymer chains 110. The hydrogel 300 may also include a functional group 230 coupled to the polymer chains 110, and its configuration is similar to the second functional group 130, such as the reference Figures 1A to 1F and Figure 2C The hydrogel 300 can be stabilized by reversibly cross-linking the functional groups 230, for example, as described in reference Figure 1C The resulting reversibly cross-linked hydrogel can then be used, for example, as described in Figures 1D to 1F Use in the manner described.
[0071] Note, reference Figures 1A to 1F , FIG. 2A to FIG. 2C and Figure 3 The specific composition and specific operation sequence described can be appropriately modified in a variety of different ways. For example, a reversibly cross-linked hydrogel comprising amplification primers 121, 122 (e.g., reference Figure 1C The hydrogel 102 can be prepared by a manufacturer and can be stable for storage and transportation to another entity (such as a customer). The entity can seed the polymer with a target polynucleotide (e.g., to form a reference Figure 1D The entity may then reverse the crosslinks 131 to open the hydrogel (e.g., to form a reference Figure 1E The entity can then amplify the seeded target polynucleotides, wherein the crosslinks have been reversed to form clusters (e.g., to form a reference Figure 1F The hydrogel 105) may optionally be swollen by the entity after reversing the cross-linking and before amplification.
[0072] As further described above, seeding is not necessary prior to reversing the crosslinking of the hydrogel. Illustratively, the hydrogel can be crosslinked after coupling the amplification primers so as to be similar to the reference Figures 1A to 1C The cross-linked hydrogel 102 is provided in the manner described. Figure 1D Although the cross-linked hydrogel 102 is not seeded in the manner described above, in some examples, the cross-links within the hydrogel 102 can be reversed prior to seeding. For example, FIG. 8A to FIG. 8B Additional exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated. Fig. 8A The hydrogel 801 exemplified in FIG. Figure 1E The method of cleavage reference Figure 1C The cross-linking in the hydrogel 102 is generated, and the cross-linking in the hydrogel 102 is omitted as shown in the reference Figure 1D After the crosslinks are cleaved to form the hydrogel 801 including the amplification primers 121 and the broken crosslinks 131', the Figure 8B The hydrogel is seeded with target polynucleotide 160 in the manner illustrated in FIG. 8 to form hydrogel 802, which is similar to hydrogel 104 described above, but obtained by a different operation.
[0073] Additionally or alternatively, as further described above, reversing crosslinking need not be performed at all or completely prior to amplification. Instead, amplification may be performed partially or completely prior to reversing crosslinking. For example, FIG. 9A to FIG. 9B Additional exemplary compositions and operations in a process flow for cluster amplification using reversibly cross-linked hydrogels are schematically illustrated. Fig. 9A The hydrogel 901 exemplified in FIG. Figure 1F Cluster amplification was performed as described above to generate the Figure 1D The seeded cross-linked hydrogel 103. Note that the hydrogel 901 may include Figure 1FThe hydrogel 105 described herein has significantly fewer amplicons 160' because significantly fewer amplification primers 121 are accessible to amplification reagents due to the crosslinking of the hydrogel 901. For example, amplicons 160' may be generated using amplification primers 121 that are close enough to the outer surface of the hydrogel 901 to be useful for cluster amplification, while other amplification primers 121 deeper within the hydrogel 901 may still be inaccessible for cluster amplification due to the crosslinking. The crosslinking within the hydrogel 901 may then be used as described in reference to Figure 1E The method described above is to provide a hydrogel 902 including amplification primers 121 and broken crosslinks 131'. Fig. 9B ). Optionally, similar to reference Figure 1F The described method uses the newly accessible amplification primer 121 to further amplify the amplicon 160' to Figure 1E to Figure 1F The various series of operations form the hydrogel 105 .
[0074] Some non-limiting examples of functional groups and their use to form reversible crosslinks within hydrogels will now be provided.
[0075] Any suitable functional group can be included in the hydrogel and used to couple the amplification primers 121, 122 to the hydrogel and / or reversibly crosslink the polymer chains 110 of the hydrogel to each other. In some examples, the functional groups (e.g., 120, 130 and / or 230) can be independently selected from the group consisting of: azide, amine, thiol, diol, aldehyde, alkyne, strained cyclooctyne and inverse electron demand (IED) Diels-Alder group. During the synthesis of the hydrogel, the functional group can be included in the polymer chain 110 of the hydrogel 100, 200 or 300. The crosslink density can be controlled by adjusting the content of the functional moieties 120, 130 and / or 230 in the polymer chain. Additionally, as described above with reference to FIG. 2A to FIG. 2C Said, one type of functional group in the hydrogel can be converted into another type of functional group. In a non-limiting example where the functional group 120 includes azides, the first group of azides is used to couple the amplification primers 121, 122 to the polymer chain 110, and the second group of unreacted azides is reduced to amines, which are used as functional groups 130 to crosslink the polymer chains 110 to each other via crosslinker molecules 131 including amine-reactive functional groups. Optionally, any suitable number of azides can be coupled to heterobifunctional molecules, which include one or more different types of azide-reactive functional groups (such as alkynes or DBCO) and also have orthogonal functional groups (such as amines, thiols, diols, aldehydes or anti-electron demand (IED) Diels-Alder groups). These functional groups can be used to crosslink the hydrogel using cleavable molecules that react with them.
[0076] As mentioned above Figure 1A to Figure 1BAs described, the amplification primers 121, 122 can be coupled to a functional group that reacts with the functional group 120 in such a manner that the amplification primers 121, 122 are coupled to the polymer chain 110. In the example where the functional group 120 is an amine, non-limiting examples of functional groups that can be coupled to the amplification primers 121, 122 and can react with the amine to couple the amplification primer to the polymer chain include: N-hydroxysuccinimide (NHS) ester, imidate, pentafluorophenyl ester, hydroxymethylphosphine and carboxylcarbodiimide. In the example where the functional group 120 is a thiol, non-limiting examples of functional groups that can be coupled to the amplification primers 121, 122 and can react with the thiol to couple the amplification primer to the polymer chain include: maleimide, halogenated acetyl, pyridyl disulfide, thiosulfonate and vinyl sulfone. In the example where the functional group 120 is an aldehyde, non-limiting examples of functional groups that can be coupled to the amplification primers 121, 122 and can react with the aldehyde to couple the amplification primers to the polymer chain include: hydrazides, alkoxyamines, and isocyanates. In the example where the functional group 120 is an azide, non-limiting examples of functional groups that can be coupled to the amplification primers 121, 122 and can react with the azide to couple the amplification primers to the polymer chain include: alkynes, cyclooctynes, phosphines, and norbornenes. In the example where the functional group is a diol, non-limiting examples of functional groups that can be coupled to the amplification primers 121, 122 and can react with the diol to couple the amplification primers to the polymer chain include: sulfonyl fluoride; unreacted diols that can be converted into dialdehydes that can be used to crosslink polymer chains. In the example where the functional group 120 is an IED Diels-Alder group, non-limiting examples of IED Diels-Alder groups that can be coupled to the amplification primers 121, 122 and that can react with the functional group 120 to couple the amplification primers to the polymer chain include: trans-cyclooctene or norbornene (which can react with the functional group 120 being tetrazine); tetrazine (which can react with the functional group 120, i.e., trans-cyclooctene or norbornene). It should be understood that any combination of the above functional groups can be used; for example, the functional group coupled to the amplification primer can include: amine, thiol, diol, aldehyde, or IED Diels-Alder group, and the functional group 120 can be selected to react with such functional groups in a manner similar to that described above.
[0077] With reference such as Figure 1C to Figure 1E , Figure 2C and Figure 3 In the manner described, the functional groups 130, 230 can be used to reversibly crosslink polymer chains in any suitable manner. In some examples, the functional groups 130, 230 reversibly crosslink polymer chains via cleavable molecules. For example, the cleavable molecules can form covalent bonds with the functional groups 130, 230, which are coupled to different polymer chains 110 from each other, such as Figure 1CThose polymer chains can be covalently cross-linked to each other in the manner illustrated in . The cleavable molecule can include, for example, aliphatic, aromatic, hydrophilic or amphipathic moieties. The cleavable molecule can be cleaved in any suitable manner, for example using a chemical agent, enzyme, light or heat. For example, the cleavable molecule can include at least one unstable bond that can be cleaved upon application of a stimulus such as a chemical agent, enzyme, light or heat.
[0078] Figure 6 An exemplary cleavable molecule 600 that can be used to reversibly crosslink a hydrogel in a manner such as described herein is schematically illustrated. Molecule 600 includes a first functional group 601, a second functional group 601', an optional first linker 602, an optional second linker 602', a first cleavable component 603, and a second cleavable component 603'. The first linker 602 can couple the first functional group 601 to the first cleavable component 603; alternatively, if the first linker 602 is omitted, the first functional group 601 can be directly coupled to the first cleavable component 603. The second linker 602 can couple the second functional group 601' to the second cleavable component 603'; alternatively, if the second linker 602' is omitted, the second functional group 601' can be directly coupled to the second cleavable component 603'. The first cleavable component 603 can be coupled to the second cleavable component 603' in a first, relatively closed state of the hydrogel, and can be decoupled from the second cleavable component in a second, relatively open state of the hydrogel. The first functional group 601 can be coupled to a first functional group in the functional groups 130, and the second functional group 601' can be coupled to a second functional group in the functional groups 130, such as with reference to Figure 1C Thus, the molecule 600 can couple the first polymer chain 110 of the hydrogel 101 (to which the first functional group of the functional groups 130 is coupled) to the second polymer chain 110 (to which the second functional group of the functional groups 130 is coupled), so that the hydrogel exhibits a relatively closed, more highly cross-linked configuration 102, such as that described in reference Figure 1C described.
[0079] The optional linkers 602, 602' may have the same configuration as each other, or may have different configurations from each other. In some examples, one linker 602, 602' is used and the other linker is omitted. The optional linkers 602, 602' may independently include an alkyl chain, Polyethylene glycol (PEG), peptides or polyphosphates, such as exemplified below: wherein * represents a connection to the first or second functional group 601 or 601' or to the first or second cleavable component 603, 603', R1 and R2 represent residues of natural or non-natural amino acids, and X represents a natural nucleoside or a spacer such as PEG or an alkyl. In non-limiting examples, n can range from about 1 to 100, or from about 2 to about 80, or from about 5 to about 50, or from about 2 to about 16.
[0080] Still refer to Figure 6 , the first cleavable component 603 and the second cleavable component 603' can correspond to any components of molecules that can be coupled to each other at a first time and can be uncoupled from each other at a second, different time in response to exposure to a suitable stimulus. For example, the first cleavable component 603 and the second cleavable component 603' can be covalently bonded to each other at a first time, such as when the hydrogel is in a relatively closed state (such as reference Figure 1C and Figure 1D and the covalent bond can be dissociated at a second time, for example, by Figure 1E Table 1 below lists different types of chemical bonds that can be used to couple the first cleavable component to the second cleavable component 603', as well as different types of stimuli (eg, chemical, enzymatic, or photolabile stimuli) that can be used to dissociate such bonds and specific examples of such stimuli.
[0081]
[0082] Non-limiting examples of cleavable components having covalent bonds that can be dissociated using chemical stimuli such as those listed in Table 1 are as follows:
[0083]
[0084] Wherein A and Q (if shown) correspond to the first functional group or the second functional group 601 or 601 ', X and M (if shown) correspond to the first linker or the second linker 602, 602 ', wherein the wavy line (if shown) corresponds to the first functional group or the second functional group 601 or 601 'or the first cleavable component or the second cleavable component 603, 603 ', and wherein R corresponds to a functional group including one or more carbon atoms and optionally including one or more heteroatoms, such as an alkyl, allyl or aryl group. For further details on chemically cleavable linkers, see Leriche et al., "Cleavable linkers in chemical biology", Bioorg. Med. Chem. Vol. 20 No. 2: pp. 571-782 (2012), the entire contents of which are incorporated herein by reference.
[0085] Non-limiting examples of cleavable components having covalent bonds that can reversibly associate and dissociate using thermal stimulation are as follows:
[0086]
[0087] wherein R and R' are the same as or different from each other and include functional groups that react with functional groups on the polymer in a manner such as described elsewhere herein.
[0088] In some examples where the cleavable molecule is capable of being cleaved by a chemical agent, the chemical agent may include an acid. Non-limiting examples of labile moieties include acetals, ketals, imines, hydrazones, or tert-butyl esters, which include bonds that can be cleaved by an acid, such as by using a buffer having a pH of about 5 or less. Examples of cleavable molecules are illustrated below, where the ketal moiety may be replaced by any of the alternative labile moieties illustrated below the molecule:
[0089]
[0090] For further details on pH-sensitive linkers comprising imine, hydrazine or acetal moieties, see Myrgorodska et al., “A novel acid-degradable PEG cross-linker for the fabrication of pH-responsive soft materials,” Macro-Molecular Rapid Communications, Vol. 42, No. 12: 2100102 (2021), the entire contents of which are incorporated herein by reference.
[0091] In a specific non-limiting example, the acid may include periodic acid, sodium periodate, or lead tetraacetate. The cleavable molecule may include a vicinal diol capable of being cleaved by periodic acid. Non-limiting examples of cleavable molecules including vicinal diols capable of being cleaved by periodic acid are:
[0092]
[0093] Wherein A and Q correspond to the first functional group or the second functional group 601 or 601 ′, and X and M correspond to the first linker or the second linker 602 , 602 ′.
[0094] In other examples where the cleavable molecule can be cleaved by a chemical agent, the chemical agent can include a reducing agent. A non-limiting example of an unstable bond is a disulfide bond that can be cleaved using a reducing agent. Another non-limiting example of an unstable bond is an azidoalkyl ether that can be cleaved using a reducing agent. Another non-limiting example of an unstable bond is an allyl ether that can be cleaved using a palladium complex of a reducing agent. Illustratively, the reducing agent can include glutathione, dithiothreitol (DTT), β-mercaptoethanol (BME), cystamine, or tris(2-carboxyethyl)phosphine (TCEP). Non-limiting examples of cleavable molecules with disulfide bonds that can be cleaved using a reducing agent are:
[0095]
[0096] wherein A and Q correspond to the first or second functional group 601 or 601', and X and M correspond to the first or second linker 602, 602'. Non-limiting examples of cleavable molecules having an azidoalkyl ether that can be cleaved using a reducing agent are:
[0097]
[0098] Wherein A and Q correspond to the first functional group or the second functional group 601 or 601 ′, and X and M correspond to the first linker or the second linker 602 , 602 ′.
[0099] Figure 7 Additional exemplary cleavable molecules 701, 711, 721 that can be used to reversibly crosslink a hydrogel in a manner such as described herein are schematically illustrated. Molecule 700 includes a first functional group 701, a second functional group 701', a first linker 702, a second linker 702', and a cleavable component 703, which can be similar to the reference Figure 6 The described manner includes a first cleavable component and a second cleavable component. The first linker 702 can couple the first functional group 701 to the cleavable component 703; alternatively, if the first linker 702 is omitted, the first functional group 701 can be directly coupled to the cleavable component 703. The second linker 702' can couple the second functional group 701' to the cleavable component 703; alternatively, if the second linker 702' is omitted, the second functional group 701' can be directly coupled to the cleavable component 703. The cleavable components can be coupled to each other in a first relatively closed state of the hydrogel, and can be uncoupled from each other and / or can be completely or partially removed from the molecule 701 in a second relatively open state of the hydrogel. The first functional group 701 can be coupled to a first functional group in the functional groups 130, and the second functional group 701' can be coupled to a second functional group in the functional groups 130, such as reference Figure 1CThus, the molecule 700 can couple the first polymer chain 110 of the hydrogel 101 (to which the first functional group of the functional groups 130 is coupled) to the second polymer chain 110 (to which the second functional group of the functional groups 130 is coupled), so that the hydrogel exhibits a relatively closed, more highly cross-linked configuration 102, such as that described in reference Figure 1C In Figure 7 In the non-limiting example shown in FIG. 1 , the cleavable component 703 includes a polypeptide that can be fully or partially degraded using a protease to generate a gap 704 that causes the hydrogel to be formed in a manner such as that described in reference Figure 1E The described approach is reopened. Note that such proteases may be non-specific to polypeptides. Alternatively, cleavable component 703 may include specific peptide sequences that are recognized and specifically cleaved by lysosomal enzymes.
[0100] Figure 7 The molecule 710 illustrated in FIG. 7 includes a first functional group 711, a second functional group 711′, a first linker 712, a second linker 712′, and a cleavable component 713. The cleavable component may be similar to that of the reference Figure 6 The described manner includes a first cleavable component and a second cleavable component. The first linker 712 can couple the first functional group 711 to the cleavable component 713; alternatively, if the first linker 712 is omitted, the first functional group 711 can be directly coupled to the cleavable component 713. The second linker 712' can couple the second functional group 711' to the cleavable component 713; alternatively, if the second linker 712' is omitted, the second functional group 711' can be directly coupled to the cleavable component 713. The cleavable components can be coupled to each other in a first relatively closed state of the hydrogel, and can be uncoupled from each other and / or can be completely or partially removed from the molecule 711 in a second relatively open state of the hydrogel. The first functional group 711 can be coupled to a first functional group in the functional groups 130, and the second functional group 711' can be coupled to a second functional group in the functional groups 130, such as with reference to Figure 1C Thus, the molecule 710 can couple the first polymer chain 110 of the hydrogel 101 (to which the first functional group of the functional groups 130 is coupled) to the second polymer chain 110 (to which the second functional group of the functional groups 130 is coupled), so that the hydrogel exhibits a relatively closed, more highly cross-linked configuration 102, such as that described in reference Figure 1C In Figure 7 In the non-limiting example shown in FIG. 1 , the cleavable component 713 includes an oligonucleotide that can be fully or partially degraded using a nuclease (such as a DNase in an example where the oligonucleotide includes DNA, or an RNase in an example where the oligonucleotide includes RNA, or a protease in an example where the oligonucleotide includes a peptide nucleic acid (PNA)) to generate a gap 714 that causes the hydrogel to be formed in a manner such as in reference Figure 1E The described mode is reopened. Note that DNA enzymes may be non-specific to DNA oligonucleotides, RNA enzymes may be non-specific to RNA oligonucleotides, or proteases may be non-specific to PNA oligonucleotides. Alternatively, cleavable component 703 may include a specific oligonucleotide sequence that is recognized and specifically cleaved by a restriction enzyme.
[0101] Figure 7 The molecule 720 illustrated in FIG. 7 includes a first functional group 721, a second functional group 721′, a first linker 722, a second linker 722′, and a cleavable component 723. The cleavable component may be similar to that of the reference Figure 6 The described manner includes a first cleavable component and a second cleavable component. The first linker 722 can couple the first functional group 721 to the cleavable component 723; alternatively, if the first linker 722 is omitted, the first functional group 721 can be directly coupled to the cleavable component 723. The second linker 722' can couple the second functional group 721' to the cleavable component 723; alternatively, if the second linker 722' is omitted, the second functional group 721' can be directly coupled to the cleavable component 723'. The cleavable components can be coupled to each other in a first relatively closed state of the hydrogel, and can be uncoupled from each other and / or can be completely or partially removed from the molecule 721 in a second relatively open state of the hydrogel. The first functional group 721 can be coupled to a first functional group in the functional groups 130, and the second functional group 721' can be coupled to a second functional group in the functional groups 130, such as reference Figure 1C Thus, the molecule 720 can couple the first polymer chain 110 of the hydrogel 101 (to which the first functional group of the functional groups 130 is coupled) to the second polymer chain 110 (to which the second functional group of the functional groups 130 is coupled), so that the hydrogel exhibits a relatively closed, more highly cross-linked configuration 102, such as that described in reference Figure 1C In Figure 7 In the non-limiting example shown in FIG. 7 , the cleavable component 723 includes a polymer that can be fully or partially degraded to generate a gap 724, which causes the hydrogel to be in a state such as in reference Figure 1E In some examples, the polymer may include a (poly)ester that can be fully or partially degraded using a lipase to generate gap 724. In other examples, the polymer may include an ester containing a cross-linker that can be cleaved in a manner such as described herein, or an ester-containing oligomer / polymer that can be cleaved in a manner such as described herein.
[0102] Functional groups 701, 701', 711, 711' and 721, 721' may have the same configuration as one another, or may have different configurations from one another, and in some examples may be selected from the options provided above for functional groups 601, 601'. Linkers 702, 702', 712, 712' and 722, 722' may have the same configuration as one another, or may have different configurations from one another, and in some examples may be selected from the options provided above for linkers 602, 602'.
[0103] In some examples where the cleavable molecule is capable of being cleaved by an enzyme, the enzyme may include a restriction enzyme, and the cleavable molecule may include a restriction enzyme capable of being cleaved by a restriction enzyme such as a reference Figure 7 The oligonucleotide can include a functional group at each end that can form a covalent bond with the functional groups 130, 230 to reversibly crosslink the polymer chains 110 to each other. In other examples where the cleavable molecule can be cleaved by an enzyme, the enzyme can include a protease enzyme, and the cleavable molecule can include an enzyme that can be used to cleave the polymer chains 110 using a protease enzyme, such as reference Figure 7 The peptide can include a functional group at each end that can form a covalent bond with the functional groups 130, 230 to reversibly crosslink the polymer chains 110 to each other. Non-limiting examples of commercially available peptides that can be used as cleavable components 703 and can be cleaved using proteases are as follows:
[0104]
[0105] In some examples, Val-Cit-PABS (valine-citrulline-p-aminobenzyl alcohol) can be coupled to functional groups (such as maleimide and / or p-nitrophenyl carbonate) for cross-linking. Another example of an enzyme cleavable component 703 is a matrix metalloproteinase-2 cleavable peptide (MMP2), which can also be used for cross-linking reactive group functionalization. As provided elsewhere herein, the functional groups of the cross-linking agents of the present invention can be the same as each other, or can be different from each other.
[0106] In the example where the cleavable molecule is capable of being cleaved by light, the cleavable molecule may include a coumarin or nitrophenyl group that can be cleaved using light. Non-limiting examples of molecules that include a nitrophenyl group that can be cleaved using light at about 360 nm are:
[0107]
[0108] For further details on molecules that can be cleaved using light (optionally in combination with chemical reagents), see Leriche et al., cited above, and Hansen et al., "Wavelength-selected cleavage of photoprotecting groups: strategies and applications in dynamic systems," Chemical Society Reviews, Vol. 44: 3358-3377 (2015), the entire contents of which are incorporated herein by reference.
[0109] Figure 4 Exemplary hydrogels and exemplary cross-linking agents that can be used with such hydrogels are schematically illustrated. Figure 4 The exemplary hydrogel 400 illustrated in includes poly(N-(5-azidoacetamidopentyl)acrylamide-co-acrylamide) (PAZAM), such as described in International Patent Publication No. WO2013 / 184796, the entire contents of which are incorporated herein by reference. Figure 4 In the non-limiting example illustrated in FIG. 1 , a first subset of the functional groups 420 (e.g., azide groups) of the hydrogel 400 is obtained by, for example, Figure 1B The "primer grafting" is described in reference to Figure 1B The functional groups 420 are coupled to the oligonucleotide 411 (e.g., amplification primers) in the manner described. A second subset of functional groups 420 (e.g., azide groups) are not coupled to the amplification primers and can therefore be considered "residual." Such residual functional groups can be used to reversibly crosslink the hydrogel. The residual functional groups can optionally be modified to form another type of functional group. For example, in Figure 4 In the non-limiting example shown in FIG, a second subset of azide groups can be contacted with a reducing agent, such as a phosphine, which reduces the azide groups to amines. The grafted hydrogel having modified functional groups is then combined with a reversibly cleavable molecule 430 (such as described in more detail above, some non-limiting examples of which are described in FIG. Figure 4 ) contact. Figure 4 In the non-limiting example shown in FIG. 4 , the functional group (e.g., NHS group) of the cleavable molecule 430 reacts with the amine generated by the reaction of the azide with the reducing agent, thereby forming a reversibly cross-linked hydrogel 400′, which includes polymer chains 110 cross-linked using the reacted cleavable molecules 431. At a later time (e.g., before or after seeding and / or amplification), the hydrogel 400′ can be contacted with a suitable stimulus to cleave the cleavable molecules 431, thereby allowing the hydrogel to be reversibly cross-linked, such as in reference to FIG. Figure 1E Reopening in the manner described.
[0110] As described elsewhere herein, non-covalent interactions may alternatively be used to crosslink polymer chains 110 within the hydrogel. Illustratively, the functional groups 130, 230 may include a host molecule that reversibly crosslinks the backbone via a guest molecule. The guest molecule may be removed via salt, heat, or pH. Alternatively, the guest molecule may be removed via displacement with a binding partner of the guest molecule. For example, FIG. 5A to FIG. 5B Additional exemplary hydrogels and exemplary cross-linking agents that can be used with such hydrogels are schematically illustrated. Figure 5A The hydrogel 500 exemplified in the embodiment may be used to make Figure 4 The hydrogel 400 is prepared by reacting the functional groups of the hydrogel 400 with the main molecule 530. Figure 5A As exemplified in , the functionalized hydrogel may include a functional group X that reacts with a functional group X' of the host molecule 530. X and X' may include any suitable reactive pair of functional groups, non-limiting examples of which are provided elsewhere herein. The hydrogel is contacted with a guest molecule 532, such as Figure 5A As illustrated in . In the complexation process, the guest molecule 532 is non-covalently bonded to the reactive host molecule portion 531, which is coupled to different polymer chains 110 from each other, thereby providing a hydrogel 500' comprising cross-linked polymer chains. In the decomposition process, the non-covalent bonds between the guest molecule 532 and the host molecule portion 531 are destroyed (for example, using salt, heat or pH), causing the reversal of the cross-linked bonds that have been formed using the complexation process. In some examples, the host molecule portion 531 includes a macrocyclic side group 533 or 534, and the guest molecule 531 is appropriately selected for use with such a macrocyclic side group. A variety of host-guest partners and their binding affinities have been reported in the literature. Non-limiting examples of hydrogels 510 and 510' are illustrated in Figure 5B In, they can be used separately Figure 5A The hydrogel 510 includes a crown ether as a host molecule portion 531, which can be used with a guest molecule 532, which includes a terminal ammonium moiety coupled to a linker such as described elsewhere herein. The hydrogel 510' includes β-cyclodextrin as a host molecule portion 531, which can be used with a guest molecule 532 such as adamantane, ferrocene, or bipyridine.
[0111] In yet other examples, the functional groups of the hydrogel can be coupled to ligand molecules that reversibly crosslink the backbone via a multivalent binding protein. The multivalent binding protein can be removed using a denaturant. For example, a protein-ligand complex held by strong non-covalent interactions can be used. In a manner similar to that described with reference to macrocycle-guest binding, the hydrogel 500 can include ligand molecules 535 in its backbone, such as Figure 5AIncubation with an appropriate multivalent binding protein can induce crosslinking between chains, which can be reversed by displacing the protein with an excess of free ligand or a stimulating chaotropic agent. An example of this is the biotin-streptavidin bond, where streptavidin binds up to four biotin molecules 535. Another example is the binding between the concanavalin A protein and four specific sugars (e.g., D-glucose and D-mannose). In Figure 5B The hydrogel 510" illustrated in FIG. 5 includes a ligand 535, a non-limiting example of which is Figure 5A exemplified in, and which can use multivalent protein cross-linking. For example, strong but reversible interactions between certain proteins and their small molecule binding partners can be used to cross-link hydrogel 510". Small molecule ligands 535 bind in specific pockets of the protein via non-covalent interactions such as H-bonding, salt bridges, etc. When a protein is introduced into a polymer network with ligand side chains 535, the protein can bind to ligands from two or more different polymer chains, thereby producing a cross-linked hydrogel. Cross-linking can be reversed by introducing excess free-floating ligands to exceed the binding of the polymer side chains.
[0112] Additional Notes
[0113] It should be understood that the compositions and methods of the present invention can be used for any suitable application, such as amplification template polynucleotides. For example, although the compositions of the present invention can be used to perform "bridge amplification" or "surface-bound polymerase chain reaction", it should be understood that the compositions and methods of the present invention can be easily adapted for use with other amplification modes. One such amplification mode is "exclusion amplification" or ExAmp. Exclusion amplification methods can allow the amplification of a single target polynucleotide in each region of the hydrogel and produce a substantially monoclonal amplicon population in the region. For example, relative to the slower transport and inoculation rate of the target polynucleotide at the hydrogel region, the amplification rate of the first inoculated target polynucleotide in the hydrogel region can be faster. Therefore, the first target polynucleotide inoculated in the hydrogel region can be rapidly amplified and fill the entire hydrogel region, thereby suppressing the inoculation of additional target polynucleotides in the same hydrogel region. Alternatively, if the second target polynucleotide is attached to the same region of the hydrogel after the first polynucleotide, the relatively rapid amplification of the first target polynucleotide can fill enough regions to produce a signal strong enough to perform sequencing by synthesis (for example, the region can be at least functionally monoclonal). The use of exclusion amplification may also result in a super-Poisson distribution of monoclonal regions; that is, the fraction of regions in an array that are functionally monoclonal may exceed the fraction predicted by a Poisson distribution.
[0114] It is useful to increase the super Poisson distribution of useful clusters because more functionally monoclonal regions can produce higher quality signals and thus improve SBS; however, the region inoculated with the target polynucleotide into the hydrogel can follow a spatial Poisson distribution, in which the compromise for increasing the number of occupied regions is to increase the number of polyclonal regions. One method of obtaining a higher super Poisson distribution is to make the inoculation occur quickly and then delay among the inoculated target polynucleotides. Since the delay (termed "kinetic delay") is considered to be produced by biochemical reaction kinetics, it gives a target polynucleotide of inoculation (starting earlier than other inoculated targets). When the recombinase mediates sequence matching, the exclusion of amplification works by using a recombinase to promote primers (e.g., primers attached to the substrate region) to invade into double-stranded DNA (e.g., target polynucleotides). The compositions and methods of the present invention may be suitable for use with a recombinase to promote the intrusion of the amplification primers and orthogonal amplification primers of the present invention into the target polynucleotides of the present invention when the recombinase mediates sequence matching. Indeed, the compositions and methods of the invention may be adapted for use with any surface-based polynucleotide amplification method, such as thermal PCR, chemical denaturing PCR, and enzymatically mediated methods (which may also be referred to as recombinase polymerase amplification (RPA) or ExAmp).
[0115] Although various illustrative examples have been described above, it will be apparent to those skilled in the art that various changes and modifications may be made therein without departing from the invention. The appended claims are intended to cover all such changes and modifications as fall within the true spirit and scope of the invention.
[0116] It should be understood that any corresponding features / examples of each of the aspects of the present disclosure as described herein may be implemented together in any appropriate combination, and any features / examples from any one or more of these aspects may be implemented together with any of the features of the other (multiple) aspects as described herein in any appropriate combination to achieve the benefits as described herein.
Claims
1. A hydrogel on a substrate, the hydrogel comprising: Three-dimensional network of polymer chains; a first functional group coupled to the polymer chain; an amplification primer coupled to the polymer chain via the first functional group; and A second functional group that couples to the polymer chains and reversibly cross-links the polymer chains to each other. 2 . The hydrogel according to claim 1 , wherein the first functional group and the second functional group are different in type from each other. The hydrogel according to claim 1 , wherein the first functional group and the second functional group are of the same type as each other.
4. The hydrogel according to any one of claims 1 to 3, wherein the first functional group and the second functional group are independently selected from the group consisting of: azide, amine, thiol, diol, aldehyde, alkyne, strained cyclooctyne and inverse electron demand (IED) Diels-Alder group.
5. The hydrogel according to any one of claims 1 to 4, wherein the second functional group reversibly crosslinks the polymer chains via a cleavable molecule.
6. The hydrogel of claim 5, wherein the cleavable molecules are capable of being cleaved using a chemical agent, an enzyme, light or heat.
7. The hydrogel of claim 6, wherein the chemical agent comprises an acid.
8. The hydrogel of claim 7, wherein the cleavable molecule comprises an acetal, ketal, imine, hydrazone, or tert-butyl ester capable of being cleaved by the acid.
9. The hydrogel of claim 6, wherein the chemical agent comprises a reducing agent.
10. The hydrogel of claim 8, wherein the cleavable molecule comprises a disulfide bond or an azidoalkyl ether that can be cleaved using the reducing agent, or an allyl ether that can be cleaved using a palladium complex of the reducing agent.
11. The hydrogel of claim 6, wherein the enzyme comprises a DNase, an RNase, a protease, or a restriction enzyme, and wherein the cleavable molecule comprises an oligonucleotide capable of being cleaved using the DNase, the RNase, the protease, or the restriction enzyme.
12. The hydrogel of claim 6, wherein the enzyme comprises a protease enzyme or a lysosomal enzyme, and wherein the cleavable molecule comprises a peptide capable of being cleaved using the protease enzyme or the lysosomal enzyme.
13. The hydrogel of claim 6, wherein the cleavable molecule comprises a Diels-Alder conjugate capable of being cleaved using heat.
14. The hydrogel of claim 6, wherein the cleavable molecule comprises a coumarin or nitrophenyl group that can be cleaved using light.
15. The hydrogel of claim 1, wherein the second functional group comprises a host molecule that reversibly crosslinks a backbone via a guest molecule.
16. The hydrogel of claim 15, wherein the guest molecule is removable via salt, heat or pH.
17. A hydrogel according to claim 15 or claim 16, wherein the guest molecule is removable via displacement with a binding partner of the guest molecule.
18. The hydrogel of any one of claims 15 to 17, wherein the host molecule comprises a crown ether and the guest molecule comprises an ammonium moiety.
19. The hydrogel according to any one of claims 15 to 18, wherein the host molecule comprises β-cyclodextrin and the guest molecule comprises adamantane, ferrocene or bipyridine.
20. The hydrogel of claim 1, wherein the second functional group comprises a ligand molecule that reversibly cross-links the backbone via a multivalent binding protein.
21. The hydrogel of claim 20, wherein the multivalent binding protein is removable using a denaturing agent.
22. A method of using a hydrogel, the method comprising: depositing a hydrogel on a substrate, the hydrogel comprising a three-dimensional network of polymer chains and at least a first type and a second type of functional groups coupled to the polymer chains; coupling an amplification primer to the first functional group of the deposited hydrogel; as well as The deposited hydrogel is reversibly stabilized by reversibly cross-linking the second functional groups of the deposited hydrogel to which the amplification primers are coupled.
23. A method of using a hydrogel, the method comprising: depositing a hydrogel on a substrate, the hydrogel comprising a three-dimensional network of polymer chains, amplification primers coupled to the polymer chains, and functional groups coupled to the polymer chains; as well as The hydrogel is reversibly stabilized by reversibly cross-linking the functional groups of the deposited hydrogel to which the amplification primers are coupled.
24. A method of using a hydrogel, the method comprising: depositing a hydrogel on a substrate, the hydrogel comprising a three-dimensional network of polymer chains and first functional groups coupled to the polymer chains; coupling amplification primers to a first subset of the first functional groups of the deposited hydrogel; converting a second subset of the first functional groups into second functional groups; as well as The hydrogel is reversibly stabilized by reversibly cross-linking the second functional groups.
25. A method of using a hydrogel, the method comprising: hybridizing the target polynucleotide to an amplification primer coupled to the hydrogel; cleaving the cross-linking bonds in the hydrogel, wherein the target polynucleotide hybridizes with the amplification primer in the hydrogel; as well as The target polynucleotide is amplified using additional amplification primers within the hydrogel in which the cross-links have been cleaved.
26. The method of claim 25, further comprising swelling the hydrogel after the lysing and before the amplifying.
Citation Information
Patent Citations
Polymer coatings
WO2013184796A1
Cited By
Preparation method and application of dynamically and reversibly crosslinked high-absorptivity resin
CN121800985A
